Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Buprenorphine Hydrochloride, Naloxone · Suboxone

Small molecule · Modulator of mu-opioid receptor (OPRM1) · developed by Indivior

Approved FDA, Aug 2010
3 Registered trials

What is Buprenorphine Hydrochloride, Naloxone?

Buprenorphine and naloxone is a sublingual film combining buprenorphine, a partial agonist at the mu-opioid receptor and antagonist at the kappa-opioid receptor, with naloxone, a mu-opioid receptor antagonist. It is used in the treatment of opioid dependence, with counseling and psychosocial support as part of a complete treatment plan.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Suboxone, TM buprenorphine, SUBOXONE
Drug type
Small molecule
Targets
mu-opioid receptor (OPRM1), kappa-opioid receptor (OPRK1) (secondary target)
Mechanism
Modulator of mu-opioid receptor (OPRM1)
Therapy area
Psychiatry
Developer
Indivior
In trials of
INDV
FDA status
Approved as Suboxone (August 30, 2010), NDA022410 · FDA label

✅ FDA-approved uses

From the indications section of the FDA label (version of Dec 22, 2025). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT03993392 Phase 4 Opioid-use Disorder Completed INDV
NCT01846455 Phase 4 Hepatic Failure Completed INDV
NCT02357901 Phase 3 Opioid Dependence Completed INDV

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Chronic Hepatitis C Infection With Hepatic ComaHepatic FailureHepatic ImpairmentOpioid DependenceOpioid Related DisordersOpioid-use Disorder

Other drugs acting on OPRM1

Sources

Updated Oct 18, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.